Deep Dive: Deep Dive Into Disparities in Opioid Access for Cancer

CancerNetwork® spoke with Andrea C. Enzinger, MD, an assistant professor of medicine at Harvard Medical School and a physician at Dana-Farber Cancer Institute, about a recent study that aimed to determine the prevalence of racial and ethnic disparities in end-of-life opioid access among Black, Hispanic, and White patients with cancer. After reviewing the study results—which highlighted a substantial gap in access among Black and Hispanic patients—Enzinger discussed how a potential multi-pronged strategy may work to mitigate these disparities including bias training for physicians and logistical support for patients.